Find Clinical Trials
Long-term (3 years) ophthalmic safety and cardiac efficacy and safety of ivabradine administered orally at the therapeutic doses (2.5/5/7.5 mg b.i.d.) on top of anti-anginal background therapy, to patients with chronic stable angina pectoris. An international, double-blind placebo controlled study.
Servier Protocol Code:
CL3-16257-067
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2006-005475-17
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- Coronary Artery Disease
- IVABRADINE
- S016257
Other study id numbers
Other identification numbers the study may be known by.
- CL3-16257-067